AIIMS Patna

Patna’s All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for Covaxin. Covaxin, a Covid-19 vaccine is being manufactured by Bharat Biotech. The company has received the…

View Post

Latest News
Spotlight

Bharat Biotech, Zydus Cadila Start Human Trials For Covid-19 Vaccine

July 18, 2020 13:02
Healthwire Bureau

New Delhi: Bharat Biotech and Zydus Cadila kicked off human trials for their Covid-19 vaccine candidates this week, inoculating the first set of participants in what will be a closely…

View Post

Spotlight

AIIMS-Patna To Start Clinical Trials Of COVAXIN

July 8, 2020 13:28
Healthwire Bureau

The clinical trials of Covid-19 vaccine — Covaxin — will begin at All India Institute of Medical Sciences (AIIMS)- Patna on July 10. AIIMS-Patna is among the 12 medical institutes…

View Post

Menu

AIIMS Patna

COVID-19: Covaxin Clinical Trials For Children Begin At AIIMS Patna

Bharat Biotech, Zydus Cadila Start Human Trials For Covid-19 Vaccine

AIIMS-Patna To Start Clinical Trials Of COVAXIN

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?

India Achieves Significant Progress in Reducing Malaria Cases: WHO Report